(2026). Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors. ClinicoEconomics and Outcomes Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors."
ClinicoEconomics and Outcomes Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors."
ClinicoEconomics and Outcomes Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.